REPAIR OF RUPTURED MEMBRANE BY INJECTION OF NATURALLY OCCURRING PROTEIN IN AMNIOTIC FLUID SAC

Abstract: The present invention provides compositions and methods for use in treatment of premature rupture of membrane. The compositions of the invention include a therapeutic amount of an avian thick egg white composition. Preferably, the compositions include the purified thick egg white protein, ovomucin. The methods of the invention involve injecting an effective amount of the compositions into the prematurely ruptured amniotic sac of a patient in order to seal the rupture.

Description: DESCRIPTION REPAIR OF RUPTURED MEMBRANE BY INJECTION OF NATURALLY OCCURRING PROTEIN IN AMNIOTIC FLUID SAC BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of obstetπcs and/or peπnatal medicine More particularly the invention relates to repair of pre-partuπtion rupture of the amniotic fluid sac 2. Description of Related Art Premature rupture of membranes (PROM) during the second and early third trimester of human pregnancy creates a management dilemma for obstetπcians There are currently many management protocols for PROM Recent literature argues the πsks and benefits of tocolytic agents, antibiotics, and corticosteroid injections pπmaπly for delaying delivery, preventing intraamniotic infection, and enhancing fetal matunty, respectively, in the event of almost certain preterm delivery However, to date, no true accepted treatment for PROM exists Medhne searches of this topic reveal only scant data in Italian studies on intracervical instillation of fibπn glue, and Japanese attempts at mechanical blockage of the cervix using double balloon-tipped catheters The ideal therapy for PROM in the absence of chonoamnionitis, and deciduitis (infections implicated in premature rupture and preterm labor) would seem to be to recreate an intact amniotic fluid sac using a benign sealant injected into the amniotic sac using needles no bigger than those now commonly used for amniocentesis By recreating the integπty of the ammon, such a technique would provide a barπer to ascending infection from the normal bacteπal flora of the cervix and vagina commonly isolated in most all obstetπc and gynecologic infections Such a technique would also allow reaccumulation of normal amniotic fluid volumes, thus protecting the fetus from compression of its own umbilical cord Chicken egg white is a cross species analog to amniotic fluid, providing protection, cushioning, and nutπtive substances essential to the surv ival of the unborn chick The cross linking of this colloid substance at the site of membrane rupture in the human gestation may provide an adequate sealant m the event of PROM The inherent properties of egg white colloid include immiscibility with water (hydrophobic), thus creating a bolus effect when encountenng the leakage site after injection into a water filled cavity The most gelatinous portion of the thick egg white component is of substantially low enough viscosity to allow injection via a standard 18 to 20 gauge spinal needle commonly used for amniocentesis SUMMARY OF THE INVENTION The present invention overcomes these and other drawbacks of the pπor art by providing methods and compositions for treating premature rupture of membranes (PROM) duπng pregnancv The methods and compositions provided result in prolonged gestation, decreased πsk of infection and umbilical cord compression, and an increased likelihood of a mature fetus In one aspect, the invention provides a method of sealing a ruptured amniotic membrane by introducing an effective amount of an avian thick egg white composition into an amniotic fluid sac of a mammal It is envisioned that the thick egg white from any type of avian egg will be effectn e in the present invention The preferred composition will include chicken thick egg white For administration of the into the amniotic fluid sac of a mammal, it is preferred that the composition additionally include any known pharmaceutically acceptable earner It is not believed that the pharmaceutically acceptable earner is absolutely necessary in the method of the invention however It is believed that the component of thick egg white that is most important in accomplishing the objectives of the invention is the protein known as ovomucin Therefore, in preferred embodiments, the composition for use in the method of the invention includes isolated and punfied o\ omucm or an ovomucin composition It is envisioned that the ovomucin in the composition of the invention may be present in concentrations of about 1 to 90 percent by weight It will be understood that this range of concentrations includes all integers and fractions contained between the range of 1 to 90 percent That is, the range is meant to include concentrations of 1 , 2, 3, 4 10, 11 , 12, 13, 14, 20, 21, 22, 23. 24, 30, 31 , 32, 33, 34, 50, 51, 52. 53, 54, 80, 81, 82, 83, 84, and so on, including fractions of a percentage, such as 1 1. 1 2, 1 3, 2 1, 2 2, 2 3, 5 1, 5 2, 5 3, 10 1, 10 2. 10 3 and so on up to about 90 percent bv weight In certain prefeπed embodiments, the thick egg white composition further compnses one or more antibiotics The thick egg white composition for use in the method of the invention will typically be introduced into the amniotic sac by an injection procedure, such as an ammoinfusion procedure Another aspect of the invention provides a method of enhancing the integnty of a ruptured amniotic membrane by contacting the ruptured amniotic membrane with an effective amount of an avian egg white glycoprotem composition Preferably, the avian egg white composition will be a chicken thick egg white composition Most preferably, the thick egg white composition will include a pharmaceutically acceptable earner The thick egg white composition will generally compnse an ovomucin composition where the ovomucin will be isolated substantially away from other thick egg white components and punfied The ovomucin may be present in concentrations of 1 to about 90 percent by weight In certain preferred embodiments, the thick egg white composition will further include one or more antibiotics It is envisioned that the thick egg white composition will typically be introduced into the amniotic sac of a patient using an injection procedure Preferably, the injection procedure will be an ammoinfusion procedure, such as ammocentesis Another embodiment of the present invention provides a pharmaceutical amniotic membrane sealant composition compnsing an effective amount of a stenle a\ ιan egg white glycoprotem composition and one or more pharmaceutically acceptable preservatives The composition of the invention may further include a pharmaceutically acceptable earner and/or at least one antimicrobial agent in a therapeutically effective amount The present invention further provides a kit for use in a method of sealing a ruptured amniotic membrane including a thick egg white glycoprotem composition in a suitable vial or container Preferably, the thick egg white composition will include isolated and punfied ovomucin with a punty of about 80% to about 95% The egg white composition may be present in the vial in powder form or gel form or in a solution including a pharmaceutically acceptable preservative and/or a pharmaceutically acceptable earner In certain aspects, such as when the composition is in powder or gel form, a pharmaceutically acceptable earner may be added directly to the vial, mixed gently, drawn into an appropriate needle for injection, and injected into a patient having a ruptured amniotic membrane BRIEF DESCRIPTION OF THE DRAWINGS The following drawings form part of the present specification and are included to further demonstrate certain aspects of the present invention The invention may be better understood by reference to one or more of these drawings in combination with the detailed descnption of specific embodiments presented herein FIG. 1A Thick egg white injected into water filled balloon via 20G spinal needle FIG. IB Successful occlusion of 20G holes m balloon by thick egg white FIG. 2 Condom-balloon apparatus simulating utenne lining (condom) and amnion (balloon) Successful occlusion using thick egg white FIG. 3 Physiologic in vitro evaluation of thick egg white occluding six 1 2 mm (18G) holes in human amnion Saline solution was utilized to recreate a resting utenne tone of 12 cm water pressure DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS Premature rupture of membranes (PROM) dunng pregnancy is currently attnbuted pnmanly to infection preceding rupture More specifically, PROM is caused by rhexis of the amnion, especially in the area in contact with the utenne cervix Rhexus of the amnion may be cause by (1) physical weakening of the amnion, (2) elevation of intrautenne pressure, and (3) dilation of the cervix Infection may accompany each of these conditions, all of which interact with each other It has been discovered that amniotic fluid may not be stenle, contrary to previous beliefs For example, Miller et al (1980) showed that bactenal colonization of amniotic fluid might exist despite intact membranes, suggesting that bactena can pass through the fetal membrane Galask et al (1984) demonstrated in vitro that anaerobes and group B streptococci (GBS) could easily mvade the membrane Subclimcal chonoammonitis is believed to be a cause of ldiopathic premature labor Many genital bactena are known to produce both phosphohpase A 2 and phosphohpase C, which can stimulate increased release of arachidonic acid and prostaglandin production within the uterus Bejar et al (1981 ) have shown that some genital bactena release a phosphohpase enzyme, thereby activating arachidonic acid metabolism in fetal membranes and stimulating the biochemical components of labor Huddleston ( 1982) argues that the release of phospholipase A 2 from the fetal membrane tnggers labor and leads to prostaglandin synthesis in the placental membrane Although the fetal membrane is normally v ery strong, clearly it is possible for it to become mechanically fragile The only reasonable explanation for weakening of the membrane is colonization with vaginal flora Bactenal inv asion of the fetal membrane causes local inflammation, i e , focal chonoammonitis, with loss of membrane mtegnty leading to PROM Bactenal enzymes and host products secreted in response to infection may add to the weakening and rupture of the membranes Resistance to infection depends on natural physiologic and mechanical barners such as the endocervical mucus plug, intact fetal membranes and antimicrobial properties of amniotic fluid PROM destroys those barners If PROM is left untreated, labor ensues, and the fetus is delivered with premature function of vanous organs For example, when a baby is born with premature pulmonary function, he is likely to dev elop respiratory distress syndrome (RDS) Severe prematunty and immature epithelial lining of the germinal matnx in the brain or of the lining of the inter intestines can predispose the neonate to intraventncular hemorrhage (IVH) and necrotizing enterocohter (NEC), respectively Therefore, it is desirable to prolong the gestation of the fetus Typically, a patient who has suffered premature membrane rupture is immobilized in bed and sometimes given a tocolytic agent and an antibiotic This treatment has often not proved sufficient to prevent maternal and fetal infections or labor, thus still often resulting in premature birth Thus, while the infusion of antibiotics and other agents may be helpful, it would be more effective to provide some sort of physical plug or barrier to ascending infection Such a barner would also prevent the leakage of amniotic fluid out of the amniotic sac and aid in prolonging the gestation The inventor has discovered that the gelatinous nature of avian egg white and proteins within it are effective to create a seal of a membrane rupture when injected into the amniotic sac While it is believed that the white from virtually any avian egg will be effectiv e in the methods of the present invention, the examples herein focus pnmanly on the chicken egg white Chicken egg white is a cross species analog to amniotic fluid, providing protection, cushioning, and nutntive substances essential to the survival of the unborn chick The cross linking of this colloid substance at the site of membrane rupture in the human gestation may provide an adequate sealant in the event of PROM The inherent properties of egg white colloid include immiscibility with water (hydrophobic), thus creating a bolus effect when encountenng the leakage site after injection into a water filled cavity The most gelatinous portion of the thick egg white component is of substantially low enough viscosity to allow injection via a standard 18 to 20 gauge spinal needle commonly used for ammocentesis Chicken egg white exists as layers of thick egg white and thin egg white The total egg white is more than 50% thick egg white, which is anchored by the chalazae to the surface of the yolk membrane The chalazae and at least part of the thick egg white are closely related physically and probably chemically In fact, the chalazae cannot be removed from the egg without teanng it from the egg white The fibers of chalazae appear to become finer and finer until they admix and "disappear " ' into the thick egg white Thick and thin egg white differ both physically and chemically Physical separation of the thick and thin egg white is currently only possible by crude and approximate means The most simple and obvious method is to cut the thin and thick white away from one another in the broken-out egg Another commonly used method is to separate the egg whites by means of passing the egg white through sieves with large diameter holes Ovomucin has been punfied to about 90% punty by French scientists using a Sepharose gel electrophoresis process The chemical differences between the thick and thm egg white include the following When egg white is diluted and acidified, approximately four times the amount of precipitate is obtained from thick egg white as from thm egg white This precipitate is called crude ovomucin Ovomucin is believed to be the component responsible for the sealant properties of the egg white m the present invention Additionally, thick egg white contains approximately four times the amount of inhibitory activity against the hemagglutination of erythrocytes by viruses Thick egg white also contains approximately 30-40% more N-acetyl-neuramimc acid (sialic acid) than does thin egg white Chalazae, extracts of crude yolk membranes, and ovomucin also possess certain similarities between them For example, all three are relatively high m sialic acid and in inhibitory activity for viral hemagglutination These similanties support the hypothesis that the fibers in thick egg white, the chalazae, and the contiguous layer of thick egg white which is intimately associated with the true yolk membrane are closely related, if not identical, substances These observations are also consistent with Conrad and Phillips' hypothesis that the chalazae is formed from the ovomucin fibers in the thick egg white as the egg passes down the hen's oviduct Conrad and Phillips (1938) speculate that while the entire egg rotates slowly dunng its oviductal passage, the yolk remains steady and does not rotate with the rest of the egg As a consequence, the ovomucin fibers are slowly turned and twisted into what eventually becomes the chalazae There are, however, no direct observations to substantiate this attractive mechanical theory for the formation of chalazae The egg white is known to be pnmanly a solution of proteins with a relatively small amount of sugar and salts Hence, the biochemist generally prefers to use avian egg white when he desires to separate, fractionate, and prepare punfied proteins in quantity That the egg white is pnmanly a solution of proteins makes the job of protein separation and purification much easier than with many other biological matenals Indeed, several egg white proteins have become standard proteins for biochemists For example, chicken ovalbumm and lysozyme have been two of the less expensive and highest punty proteins available for many years The pπmary protein of chicken egg white is ovalbumin The concentration of ovalbumm in egg white is about four to five times the concentration of the secondary constituents, ovotransfemn, and ovomucoid Thus, ovalbumm provides the pnmary properties of egg white with the other constituents contnbuting mainly to the biological properties of the egg white Ovumucin is an exception to this general rule Ovomucin appears responsible for the high v iscosity of thick egg white Many different procedures are available for fractionating chicken egg white for the preparation of the individual proteins These procedures are well within the skill or the ordinary artisan and include salt fractionation techniques and fractionation with cellulose ion-exchange agents Additionally, senal acidification, precipitation, centπfugation and alkali resuspension can be used to separate and punfy ovomucin PROPERTIES OF EGG-WHITE PROTEINS Ovalbumm is the pnncipal protein of chicken egg white and is also the only major constituent for which no unique biochemical activity has been found The main property of ovalbumm has been its sensitivity to denaturation Ovalbumm is known to have some interesting chemical aspects not directly related to sequence One such interesting aspect is its heterogeneity due to the presence of either one or two phosphates Another interesting aspect is the number and reactivity of the cysteine sulfhydryl groups Yet another is the structures of the side-chain carbohydrates and linkages of the carbohydrates to the peptide chain Avidm is another protein prominent in egg white In 1941 Eakin, Snell, and Williams concentrated avidin using acetone and salt fractionation procedures They then performed a modified biotm microbial assay designed for avidin A unit was defined as the amount of concentrate capable of inactivating 1 gram of biotm Raw egg white vaned from 0 8 to 1 2 units/cc Free avidin appears to be an albumin-like protein, although it probably occuned in egg white to varying extents as the above mentioned complexes Chicken egg-white flavoprotein (or ovoflavoprote ) is one of two egg-white proteins which contains, or can bind, a B-vitamm The other is avidin Rhodes, Bennett, and Feeney (1959) found ovoflavoprotem to exist in two forms, one form, flavoprotein, contains nboflavin and the other, apoprotein, does not The total concentration of the two forms is approximately 0 8% of the egg white Ovomacroglobuhn is the only detectable component of avian egg whites to have a wide spectrum of immunological cross-reactivity It also appears to be strongly immunogenic Deutsch (1953) reported that a large part of the capacity of egg white to produce antibodies was probably a minor unrecognized fraction of the egg white The ovomacroglobuhn might be this fraction Ovomacroglobuhn is a very large protein with an estimated molecular weight of approximately 800,000 g/mole as determined by sedimentation-velocity, diffusion, and light scattenng measurements This makes ovomacroglobuhn the largest recognized egg-white protein, other than ovomucin There is, howev er, ev idence that it dissociates into smaller units m acid solution In addition to the major proteins already descnbed, there are probably one or tw o dozen minor proteins in chicken egg white Several of these have been seen in different types of electrophoretic patterns of the egg white itself and probably many more have been seen as minor contaminating substances on punfication of the recognized constituents Lineweaver and co- workers (1948) found chicken egg white to be essentially devoid of enzymatic activities with the exception of catalase activity Some of the egg white proteins are known to have antimicrobial activity It is believed that those proteins that do show antimicrobial or antienzyme properties could potentially be used as microbial antagonists These include lysozvme, ovoflavoprotem, avidm, ovotransfemn, and the inhibitors of proteolytic enzymes, ovomucoid, and ovoinhibitor For example, lysozvme has been shown to be bactencidal to a limited number of species Ovotransfemn has also proven to be an important antimicrobial substance Egg white typically has a high pH dunng the first few days of the incubation of the egg This high pH egg white also has antibactenal activity, a factor that is usually overlooked The pH of the egg white m a freshly laid chicken egg is slightly below 7 6 and the pH of the yolk is approximately 6 0 The initial pH of 7 6 obviously closely approximates the pH of blood serum Since the egg shell contains approximately ten thousand pores, carbon dioxide escapes through the shell and the pH of the egg w hite begins increasing immediately after the egg is laid The rate of the pH increase depends on the temperature and the carbon dioxide tension The pH will nse to above 8 0 within a matter of three or four hours at room temperatures It appears that the egg white has such a high carbon dioxide content because a high carbon dioxide tension exists in the oviduct Physical changes in the egg contents occur after a few days at room temperature or a few weeks at refrigerated temperature These changes include a weakening and dissolution of the gel of the thick egg white and a weakening and eventual ruptunng of the yolk membrane The rate at which these changes occur depends on the pH of the egg white and the temperature of incubation The physical changes themselves are well known to anyone who has broken out a partially detenorated egg and observed the watery white and perhaps raptunng of the yolk membrane For this reason, it is believed that the egg white should be used w ithin about 2 days if maintained at room temperature, preferably within about 24 hours The composition could typically be usable for up to 2 weeks after purification and resuspension in a pharmaceutically acceptable earner Most preferably, the composition will be maintained at body temperature, that is, at about 37°C and will be used within about 24 hours Most investigators agree that the detenorative process in the thick egg white involves changes of the ovomucin It has been shown that egg white can be thinned and the yolk membrane weakened by adding small amounts of reducing agents such as mercaptans or sulfite (Hoover 1940, MacDonnell et al 1955) Several treatments that denature or inactivate protein prevented the changes It was further shown that other deteriorative changes in egg white were most evident by changes in the ovotransfernns These changes were apparently due to interactions of the proteins with the glucose naturally present in the egg white This glucose- protein reaction (Millard) seems to be accelerated by alkaline conditions and egg white is known to be relatively alkaline Such a glucose-protem reaction should not occur at room temperature (or 37°C) and in relatively dilute solution Several theones have been proposed for the detenorative mechanisms in egg white. The first theory is that ovomucin is reductively cleaved by reducing agents generated dunng the incubation of the white It is known that ovalbumm, which contains sulfhydryl groups, can be titrated with p-chloromercuncbenzoate (MacDonnell et al 1955) A "denaturation" of less than 1 % of the ovalbumm is likely enough to supply the potential amount of reducing agent required to thm the egg white Changes have been reported in the chromatographic charactenstics, in the solubility, and in resistance to denaturation of ovalbumm The second theory is that lysozvme and ovomucin exist in a complex that both forms and dissociates dunng incubation This changes the gel charactenstics and causes thinning The formation of a complex is supported by observations that the enzymatic activ ity of lysozvme m egg white decreases dunng incubation In fact, the assayable activities of lysozvme in egg white were found to drop extensively (up to 40%) dunng the thinning process The observed activity w as dependent on the ionic strength dunng dilution of the egg white These observations indicate an ionic type of complex involving lysozvme Another theory is that the solubility of ovalbumm changes dunng incubation It has also been postulated that the interaction of glucose with protein directly or indirectly causes thinning As discussed above, glucose interaction could indirectly cause thinning by generating reducing compounds Unfortunately, none of these theones fits all of the available data Chicken, turkey (Meleagrts gallopavo), and probably penguin (Pygoscehs adehae) eggs detenorate rapidly, while duck and goose eggs show essentially no detenoration Duck eggs are relatively low in lysozyme and very low in sialic acid, which are both considered to be related to detenoration The ovomucin fractions are known to contain sialic acid Since the penguin egg contains essentially no lysozyme and the highest amount of sialic acid observed in any bird, these latter mechanisms seem improbable Thus, a reduction mechanism or a combination of several mechanisms mav be the cause of the changes finally expressed as a change in the colloidal distribution of the high molecular weight aggregates of ovomucin The inventor has found that a composition compnsing avian thick egg white is effective to seal a membrane rupture Since egg white is a benign composition, it is believed that injection of the purified thick egg white alone will be effective in the method of the invention Alternatively, a composition containing ovomucin, the protein that causes the gelatinous nature of the egg white, may be used in the conjunction with the method of the invention In a prefened embodiment, the method of the invention includes admimstenng a composition compnsing substantially punfied ovomucin in a pharmaceutically acceptable earner in a therapeutically effective amount to a patient who has suffered a premature rupture of membrane The term "substantially punfied" refers to a ovomucin that has been isolated away from the other proteins present in thick egg white and punfied to at least about 80% punty It may also include synthetic ovomucin prepared to at least about 90% punty Preferably, the isolate and punfied ovomucin, either synthetic or natural, will be prepared to about 98% punty It is also envisioned that active fractions or epitopes of the ovomucin protein may be effective in the present invention Protein analysis to locate active epitopes and active portions of the protein chain, and preparation of peptide fractions, or truncated proteins, are well known and routine to those skilled in the art In preferred embodiments the composition may also contain one or more antibiotic or antimicrobial agents For example, antimicrobials which will be effective in the present invention include injectable penicillins or their denvatives. injectable cephalosponns or their denvatives, injectable microhde antibiotics or their denvatives, injectable ammoglycoside antibiotics or their denvatives or other naturally occurnng bactenocidal and/or bactenastatic substances found in egg white matnx The antimicrobials will be present in the composition in a therapeutically effective amount, that is, in an amount effective to eliminate or inhibit bactena present in the amniotic sac due to ascending infection or otherwise The antimicrobials for inclusion in the compositions of the invention will generally be present in concentrations that provide bactenocidal activity based on a minimum inhibitory concentration in the presence of a maximum dilution of about 3,000 mL of amniotic fluid The compositions of the invention will be injected directly into the ruptured amniotic sac of a patient who has suffered from premature rupture of membranes (PROM) Preferably, the compositions of the invention will be injected using an 18 gauge or a 20 gauge spinal needle, although it is envisioned that other sized needles, such as 18 to 25 gauge needles of vanable length may be used in conjunction with the method of the invention Preferably, about 5 to about 20 ccs will be injected into the patient's amniotic sac Most preferably, about 10 ccs will be injected into the patient who has suffered from premature rupture of membrane The following examples are included to demonstrate preferred embodiments of the invention It should be appreciated by those of skill in the art that the techniques disclosed in the examples which follow represent techniques discovered by the inventor to function well in the practice of the invention, and thus can be considered to constitute preferred modes for its practice Howev er, those of skill in the art should, m light of the present disclosure, appreciate that many changes can be made in the specific embodiments which are disclosed and still obtain a like or similar result without departing from the spint and scope of the invention Solutions of the active compounds as free base or pharmacologically acceptable salts can be prepared in water suitably mixed with a surfactant, such as hydroxypropylcellulose Dispersions can also be prepared in glycerol, liquid polyethylene glycols, and mixtures thereof and m oils Under ordinary conditions of storage and use, these preparations contain a preservative to prevent the growth of microorganisms The pharmaceutical forms suitable for injectable use include stenle aqueous solutions or dispersions, formulations including sesame oil, peanut oil or aqueous propylene glycol, and stenle powders for the extemporaneous preparation of stenle injectable solutions or dispersions In all such cases, the form must be stenle and must be fluid to the extent that easy synngabihty exists It must be stable under the conditions of manufacture and storage and must be preserved against the contaminating action of microorganisms, such as bactena and fungi The earner can also be a solvent or dispersion medium containing, for example water. ethanol, polyol (for example, glycerol, propylene glycol, and liquid polyethylene glycol. and the like), suitable mixtures thereof, and vegetable oils The proper fluidity can be maintained, for example, by the use of a coating, such as lecithin, by the maintenance of the required particle size in the case of dispersion and by the use of surfactants The prevention of the action of microorganisms can be brought about by v anous antibactenal and antifungal agents, for example, parabens, chlorobutanol, phenol, sorbic acid, thiomensal, and the like In many cases. it will be preferable to include isotonic agents, for example, sugars or sodium chlonde Prolonged absorption of the injectable compositions can be brought about by the use in the composition of agents delaying absorption, for example, aluminum monostearate and gelatin Stenle injectable solutions are prepared by incorporating the active compounds in the required amount in the appropnate solvent with vanous of the other ingredients enumerated above, as required, followed by filtered stenhzation Generally, dispersions are prepared bv incorporating the vanous stenhzed active ingredients into a stenle vehicle which contains the basic dispersion medium and the required other ingredients from those enumerated abov e In the case of stenle powders for the preparation of stenle injectable solutions, the preferred methods of preparation are vacuum-drying and freeze-drying techniques which yield a powder of the active ingredient plus any additional desired ingredient from a previously-stenle-filtered solution thereof Upon formulation, solutions will be administered in a manner compatible with the dosage formulation and in such amount as is therapeutically effective The formulations are easilv administered m a vanety of dosage forms, such as the type of injectable solutions descnbed above, with even drug release capsules and the like being employable EXAMPLE 1 Nine inch diameter helium grade water filled balloons were initially used as an in vitro model of the amniotic membrane The internal pressure as measured by manometry was between 25 - 35 cm of water Hypodermic needles of standard medical grade ere used to create puncture holes in the water filled balloons Initially, single 20 gauge (1 0 mm) holes were created through which 5 mL of thick egg white were injected into the water filled balloons (See FIG 1A) The hydrophobic egg white remained immiscible with water When the egg white bolus contacted the inner surface at the leak site, the hole was successfully plugged (FIG IB) These seals were maintained for three weeks, at which time, the integnty of the rubber of the balloon itself began to degrade Of note, the seal appeared more readily when the water inside the balloon was approximately equal to body temperature (37°C) as regulated bv a digital thermometer EXAMPLE 2 Repeated acetic acid elutions were performed on thick egg white Repeated elutions with 5% acetic acid followed by washing w ith water led to thickened and precipitated membrane in the thick egg white The thin egg white was easily separated from the thick egg white in the soluble form Resuspension occurred when the pH was made basic using ammonia Precipitation again occurred when acidic conditions were reinstated Thus, it appears that the components of thick egg white are stable to changes in pH of the suspending solution, but the v iscosity is markedly increased in acidic environments EXAMPLE 3 A dilute (5%) acetic acid was used to thicken and precipitate the thick egg white. The more viscous component was separated from the remaining egg white components. A nine-inch helium-grade balloon was then filled with water and 4 mL of acid eluted thick egg white. The balloon (inner membrane) was then placed inside a slightly water filled latex condom. This apparatus simulates the inner membrane (amnion) and outer compartment (uterus). A single 18 gauge (1.2 mm) hole was created by passing a hypodermic needle through the balloon. The thick egg white within the balloon migrated to the leak site and readily sealed the leak at the balloon/condom interface (FIG. 2). The seal was readily visualized through the transparent condom. EXAMPLE 4 Amniotic membranes from human placentas were utilized to more accurately assess in vivo activity of the thick egg white physical characteristics. Membranes from normal term placentas were attached to the distal end of a 12-inch long 1 Y 2 inch diameter common polyvinyl chloride (PVC) pipe. A single rubber band was used to secure a 12 cm x 12 cm square of amnion to the PVC pipe. Normal saline solution (0.9%) was used to fill the proximal end of the pipe to the gravitational equivalent pressure to the resting tone of a pregnant uterus. Approximately 8 mL of thick egg white was introduced into the proximal end of the pipe. Six 18-gauge (1.2 mm) holes were punctured through the amniotic membrane (FIG. 3). All holes were readily sealed using the above apparatus. The same apparatus was utilized while creating a single 1 cm tear in the amnion. The saline and egg white solution failed to seal this size tear. It is believed that the leakage through such a tear in an actual human amniotic membrane would be lessened in vivo in a system with endometrium and outer compartment (uterus) containing the inner membrane due to increased surface area and surface tension. The flow across the in vivo system would be markedly less than the full gravitational forces present in this example. The above procedure was repeated using holes of sizes 25 gauge, 22 gauge, 20 gauge and 18 gauge and a range of pressures of 10 cm, 20 cm and 30 cm of water. Some suggestion of slow leak was observed with 30 cm of water only with the 18 gauge hole. Identical results were observed using both thick meconium and normal amniotic membrane specimens suspended on PVC pipe. All of the compositions and/or methods disclosed and claimed herein can be made and executed without undue expenmentation in light of the present disclosure While the compositions and methods of this invention have been descnbed in terms of preferred embodiments, it will be apparent to those of skill in the art that vanations may be applied to the compositions and/or methods and in the steps or m the sequence of steps of the method descnbed herein without departing from the concept, spint and scope of the invention More specifically, it will be apparent that certain agents which are both chemically and physiologically related may be substituted for the agents descnbed herein while the same or similar results would be achieved All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spint, scope and concept of the invention as defined by the appended claims REFERENCES The following references, to the extent that they provide exemplary procedural or other details supplementary to those set forth herein, are specifically incorporated herein by reference. Awade. A.C. et al., Two-step chromatographic procedure for the purification of hen egg white ovomucin, lysozyme, ovotransfemn and ovalbumm and characterization of purified proteins, J. CHROMAT. A, 677: 279-288 (1994). Awade. A.C. and Efstathiou T., Comparison of three liquid chromatographic methods for egg- white protein analysis. J. CHROMAT. B, 723: 69-74 (1999). Bejar. R. et al.. Premature labor. II Bacterial sources of phospholipase, OBSTET. GYN ECOL. 57: 479 (1981 ). Conrad. R.M. and Phillips, R.E., The formation of the chalazae and inner thin white in the hen ' s egg, POULTRY SCI. 17- 143 (1938). Deutsch. H.F., Immunochenucal analysis of egg white, FED. PROC, 12: 729 ( 1953). Eakin. R.E. et al., The concentration and assay of avidin , the injury-producing protein ... raw egg white, J. BlOL. CHE . 140-535 ( 1941). Feeney, R.E. and Allison, R.G., In Evolutionary Biochemistry of Proteins: Homologous and Analogous Proteins from Avian Egg Whites, Blood Sera, Milk, and Other Substances, Wiley-Interscience ( 1969). Galask, R.P. et al., Bacterial attachment to the chorioamnwtic membranes, AM. J. OBSTET GYNECOL. 148: 915 ( 1984) HANDBOOK OF BIOCHEM. AND MOLECULAR BIO., 3D EDITION, Volume II, Gerald D. Fasman (Editor), CRC Press pp. 268-269, 486, 533, 721 (1976). Hoover, S R., A physical and chemical study of ovomucin. Ph.D Thesis, Georgetown Univ., Washington, D.C., (1940). Huddleston, J.F., Preterm labor, CLIN . OBSTET. GYNECOL. 25. 123 (1982). Imanaka & Ogita, New Technologies for the Management ofPPROM, OBSTETRICS & GYΝECOLOGY CLINICS OF N. AM., 19(2): 366-386 (1992). Kirkovsky, V.V. et al., Biospecifiic haemosorbents based on proteinase inhibitor; III Biospecifiic antiproteinase haemosorbent "Ovosorb " in complex therapy of acute destructive pancreatitis, BlOMATERIALS. 15(5) 334-336 (1994). Kishaw, P.J. and Cant, A.J., The Passage of Maternal Dietary Proteins into Human Breast Milk, INT. ARCHS ALLERGY APPL. IMMUN . 75 8- 15 ( 1984). Lmevveaver. H. et al., Enzymes of fresh hen eggs, ARCH. BIOCHEM. 16: 443 (1948). MacDonnell, L.R. et al., The functional properties of the egg-white proteins, FOOD TECHNOL. 9:49 (1955). Miller, J.M. et al., Bacterial colonization of amniotic fluid from intact fetal membranes, AM. J. OBSTET GYNECOL. 136:796 ( 1980) Plate, N.A. et al., Biospecifiic haemosorbents based on proteinase inhibitor: I nthesιs and properties, BlOMATERIALS 14(1 ): 51 -56 ( 1993) Plate, N.A. et al.. Biospecific haemosorbents based on proteinase inhibitor; II. Efficiency of biospecifiic antψroteinase haemosorbent 'Ovosorb ' in complex treatment of experimental generalized purulent peritonitis and acute destructive pancreatitis in dogs, BlOMATERIALS 15(4): 285-288 (1993). Rabouille, C. et al.. Interactions Involved in Ch'omucm Gel-Forming Properties: A Rheological- Biochemical Approach ", ARCHIVES OF BIOCHEM. & BlOPHYS., 270(2): 495-506 (1989). Rabouille et al., The Supramolecular Organization ofi Ovomucin. Biophysical and Morphological Studies, BIOCHEMICAL JOURNAL, 266(3): 697-706 (1990). Rhodes, M.B. et al, The flavoprotein-apoprotem system of egg white. J. BlOL. CHEM. 234: 2054 ( 1959). Stevens, L., Egg White Proteins, COMP. BIOCHEM. PHYSIOL. 100B(1): 1 -9 (1991 ). Strecker, G. et al., H and C-NMR assignments for sialylated oigosaccharide-alditols related to mucins. Study of thirteen components from hen ovomucin and swallow nest mucin, BIOCHIMIE 74: 39-52 (1992).

Claims: CLAIMS 1 A. method of sealing a ruptured amniotic membrane compnsing introduction of an effectiv e amount of an avian thick egg white composition into an amniotic fluid sac of a mammal 2 The method of claim 1, wherein said avian egg white composition is a chicken thick egg white composition 3 The method of claim 1 , wherein said thick egg white composition further compnses a pharmaceutically acceptable earner 4 The method of claim 1 , wherein said thick egg white composition comprises an ovomucin composition 5 The method of claim 4, wherein said ovomucin composition compnses ovomucin in the range of 1 to 90 percent by weight 6 The method of claim 1, wherein said thick egg white composition is introduced into said amniotic sac by an injection procedure 7 The method of claim 6, wherein said injection procedure is an ammoinfusion procedure 8 The method of claim 1, wherein said thick egg white composition further compnses one or more antibiotics, or bactenal inhibiting substances 9 A method of enhancing the mtegnty of a ruptured amniotic membrane compnsing contacting said ruptured amniotic membrane with an effective amount of an avian egg white glycoprotem composition 10 The method of claim 1 , wherein said avian egg white composition is a chicken thick egg white composition 11 The method of claim 1, wherein said thick egg white composition further compnses a pharmaceutically acceptable earner 12 The method of claim 1 , wherein said thick egg white composition comprises an ovomucin composition 13 The method of claim 12, wherein said ovomucin composition compnses ovomucin in the range of 1 to 90 percent by weight 14 The method of claim 1 , wherein said thick egg white composition is introduced into said amniotic sac by an injection procedure 15 The method of claim 14, wherein said injection procedure is an ammoinfusion procedure 16 The method of claim 1 , wherein said thick egg white composition further compnses one or more antibiotics, or bacterial inhibiting substances 17 A pharmaceutical amniotic membrane sealant composition compnsing an effectiv e amount of a stenle avian egg white glycoprotem composition and one or more pharmaceutically acceptable preservatives 18 The composition of claim 17, further compnsing a pharmaceutically acceptable earner 19 The composition of claim 18, further compnsing an antimicrobial agent in a therapeutically effective amount 20 A kit for use in a method of sealing a ruptured amniotic membrane, said kit compnsing a thick egg white glycoprotem composition in a suitable vial or container 21 The kit of claim 20, wherein the thick egg white composition compnses isolated and punfied ovomucin with a punty of about 80% to about 95% 22 The kit of claim 21 , wherein the egg white composition mav be in powder form or gel form or in a solution compnsing a pharmaceutically acceptable preservative with or without a pharmaceutically acceptable earner

Inventors: BERRY DAVID LEE, BERRY, DAVID, LEE
Applicants: BERRY DAVID LEE, BERRY, DAVID, LEE
Application year: 2001
Main classification: A61B
IPC codes: A61B17, A61K38